AGBL2 and interstitial lung disease: These anti-CCP2 titers were correlated with impairment in several parameters for ILD severity, including the SGRQ, 6MWT, Borg scales, decrease in FVC%, and higher scores for ILD involvement and severity identified in the HRCT severity.